Delayed Hematologic Toxicity
Delayed Hematologic Toxicity is a type of hematologic toxicity characterized by the late-onset suppression of bone marrow function, manifesting in reduced blood cell counts, following a latent period after exposure to a causative agent such as chemotherapy or radiation.
18
Publications
1.5K
Citations
131
Authors
46
Institutions
Publications per year
2017–2026
2
Variants
Delayed Hematological Toxicity
Parents
18
Early and late hematologic toxicity following CD19 CAR-T cells
Shalev Fried, Abraham Avigdor, Bella Bielorai et al. · Bone Marrow Transplantation · 2019 · 401 citations
Medicine, Hematology, Immunology +14
Clinical studies with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037).
Heine H. Hansen, Oleg S. Selawry, Franco M. Muggia et al. · PubMed · 1971 · 93 citations
Medicine, Oncology, Pharmacology +8
1–5 of 18
131
2
h-index
The University of Texas MD Anderson Cancer Center, United States
1 publications · 10 citations
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 131
46
The University of Texas MD Anderson Cancer Center
Houston, United States
2 h-index
8 publications
1.3K citations
University of California, San Francisco
San Francisco, United States
2 h-index
1 publications
62 citations
University of Miami
Coral Gables, United States
2 h-index
2 publications
386 citations
Northwestern University
Evanston, United States
2 h-index
9 publications
1.3K citations
Endeavor Health
Evanston, United States
1 h-index
1 publications
134 citations

Sheba Medical Center
Ramat Gan, Israel
1 h-index
10 publications
4K citations

St. Jude Children's Research Hospital
Memphis, United States
1 h-index
10 publications
900 citations
Phoenix Children's Hospital
Phoenix, United States
1 h-index
3 publications
159 citations
1–8 of 46
Repository · 4 publications · 186 citations
4
h-index
1 publications · 53 citations
1
h-index
JVIM · 1 publications · 16 citations
1
h-index
1 publications · 56 citations
1
h-index
1 publications · 62 citations
1
h-index
1–5